NA-global

A Summary Report of the ISPOR Asia Consortium Meeting

Oct 22, 2024

NA-global

Applications of RWD and RWE in Decision Making in Asia Pacific

Oct 2, 2024

NA-global

ISPOR Asia Consortium Industry Committee Meeting - July 1, 2024

Jun 13, 2024

NA-chapters

Professor Jing Wu on "2024 Health Policy of the Two Sessions" of the People's Daily Health

Mar 13, 2024

NA-Policy

Korea Health Policy News

Mar 13, 2024

NA-HQ

Write an AI Concerto for Pharmacoeconomics

Mar 4, 2024

NA-Policy

Singapore Policy Update: Implementation of Implant Subsidy List

Mar 4, 2024

NA-chapters

An Interview with Professor Shanlian Hu - The Trend of the 2024 Medical Insurance Drug Price Negotiation: Perspective of a Medical Insurance Expert

Mar 4, 2024

NA-HQ

The 11th HTAsiaLink Annual Conference

Nov 6, 2023

NA-global

In China, Strategic Procurement in Medical Insurance Has Become Mainstream

Nov 6, 2023

NA-Policy

Korea Health Policy News Update

Nov 6, 2023

NA-chapters

The 5th Conference of ISPOR Northwest China Chapter

Nov 6, 2023

NA-ISPOR

ISPOR Asia Consortium Industry Committee Explores Pricing Approaches in China and the US

Nov 2, 2023

NA-ISPOR

2023 ISPOR Health Technology Assessment (HTA) Roundtable – Asia Pacific

Nov 2, 2023

NA-ISPOR

Summary Report from ISPOR 2023 Patient Representatives Roundtable (PRR) – Asia Pacific 2023

Nov 2, 2023

NA-ISPOR

ISPOR Global Group Activities During ISPOR Europe 2023

Oct 19, 2023

NA-global

ISPOR Asia Pacific Health Policy Update - A Summary Report

Aug 16, 2023

NA-Policy

Korea Health Policy Updates - August 2023

Aug 11, 2023

NA-Policy

The US Drug Price Negotiations

Aug 11, 2023

NA-HQ

The 9th Northern China Annual Pharmacoeconomics Forum

Aug 11, 2023

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×